Samples | Stage | Grade | Treatment cycles | Age | Overall survival |
---|---|---|---|---|---|
Ascites 1 | IIIc | High Grade Serous | Carboplatin and Paclitaxel 6Â cycle | 39Â years at diagnosis | 3Â years and 7Â months |
Doxorubicin Pegylated Liposomal 9Â cycles | |||||
Gemcitabine and Carboplatin 3Â cycles | |||||
Paclitaxel (12 treatments in cycle 1, 3 treatments in cycles 3 through to 9) | |||||
Ascites 2 | IIa | High Grade Serous | Carboplatin 5Â cycles | 78Â years at diagnosis | 6Â months |
Ascites 3 | Unknown | Not Graded | Carboplatin and Paclitaxel 4Â cycles | 59Â years at diagnosis | 5Â months as of 20/11/2012 |
Ascites 4 | Unknown | Adenocarcinoma NOS | Carboplatin and Paclitaxel 6Â cycles | 75Â years at diagnosis | 1Â year 8Â months |
Tamoxifen 2Â cycles | |||||
Doxorubicin Pegylated Liposomal 4Â cycles | |||||
Ascites 5 | IIc | High Grade Serous | Carboplatin and Paclitaxel 4Â cycles, Topotecan 1Â cycle | 64Â years at diagnosis | 5Â months |
Ascites 6 | IIIc | High Grade Serous | Carboplatin and Paclitaxel 6Â cycles | 52Â years at diagnosis | 2Â years 5Â months |
AMG-386 182 Trial 8Â cycles | |||||
Paclitaxel 3Â cycles | |||||
Paragon Trial 2Â cycles | |||||
Carboplatin single agent 3Â cycles | |||||
Cyclophosphamide 2Â cycles | |||||
Ascites 7 | IIIc | High Grade Serous | Carboplatin and Paclitaxel 9Â cycles | 59Â years at diagnosis | 2Â years 6Â months |
Cisplatin 4Â cycles | |||||
Cyclophosphamide 2Â cycles | |||||
Ascites 8 | IV | Adenocarcinoma NOS | Carboplatin and Paclitaxel 6Â cycles | 67Â years at diagnosis | 2Â years 6Â months |
Gemcitabine and Carboplatin 6Â cycles | |||||
Ascites 9 | Unknown | Adenocarcinoma NOS | Cyclophosphamide 3Â cycles | Â | 2Â years 8Â months |
Carboplatin and Paclitaxel 6Â cycles | 65Â years at diagnosis | ||||
MORAb Trial 9Â cycles | |||||
Doxorubicin Pegylated Liposomal 3Â cycles | |||||
Ascites 10 | IIIc | High Grade Serous | Doxorubicin Pegylated Liposomal 3Â cycles | 55Â years | 5Â years 5Â months |
ICON 7 Trial 18Â cycles | |||||
ICON 6 Trial 6Â cycles | |||||
Paragon Trial 1Â cycle | |||||
Paclitaxel 6Â cycles | Â | Â | |||
Ascites 11 | IIIc | High Grade Serous | Hormonal Therapy Tamoxifen | 69Â years at diagnosis | 7Â years 11Â months |
Topotecan Hydrochloride 2Â cycles | |||||
Carboplatin and Paclitaxel 6Â cycles | |||||
Carboplatin single agent 6Â cycles | |||||
Gemcitabine and Carboplatin 6Â cycles | |||||
Carboplatin single agent 6Â cycles | |||||
Cyclophosphamide 6Â cycles | |||||
Doxorubicin Pegylated Liposomal 4Â cycles | |||||
Paclitaxel 3Â cycles | |||||
Ascites 12 | IIIc | High Grade Serous | Doxorubicin Pegylated Liposomal 3Â cycles Carboplatin and Paclitaxel 6Â cycles | 59Â years at diagnosis | 2Â years 11Â months as of 21/05/2013 |
Gemcitabine and Carboplatin 6Â cycles | |||||
Ascites 13 | IIIc | High Grade Serous | Doxorubicin Pegylated Liposomal 4Â cycles | 53Â years at diagnosis | 2Â years 11Â months as of 21/05/2013 |
Carboplatin and Paclitaxel 6Â cycles | |||||
AMG-386 182 9Â cycles | |||||
Paclitaxel 6Â cycles | |||||
Cyclophosphamide 2Â cycles | |||||
Topotecan 2Â cycles | |||||
Ascites 14 | IV | High Grade Serous | Carboplatin 1Â cycle | 46Â years at diagnosis | 2Â years 6Â months as of 13/08/2013 |
Carboplatin and Paclitaxel 6Â cycles | |||||
Ascites 15 | IIIc | Not Graded | Carboplatin 5Â cycles | 76Â years at diagnosis | 1Â year and 8Â months |
Cyclophosphamide 7Â cycles | |||||
Paragon Trial 3Â cycles |